Automated reanalysis using Talos
We’re the first lab in Australia to use Talos - a tool that enables regular, automatic reanalysis of genomic sequencing data for undiagnosed patients.
Data from all eligible undiagnosed patients from 2019 onwards will be reanalysed monthly using Talos.
Eligible tests
-
Clinical exome and WGS cases, including prenatal analysis, where a diagnosis has not been found.
-
This includes our focused and comprehensive test options but excludes targeted single variant tests and expanded carrier screening (prepair).
-
Patients can opt-out of reanalysis if referrers notify the laboratory.
What reanalysis will cover
-
Reanalysis will address the primary reason for the original request and the clinical information provided at the time will assist with variant curation.
-
We will not report incidental findings.
-
The original referring team will be contacted to discuss new findings before an amended report is issued.
-
There will be no cost for automated reanalysis using the original information.
What if there is new clinical information relevant to the patient’s phenotype?
-
If there is new clinical information available, a manual reanalysis is recommended.
-
In this case, a request for reanalysis including detailed additional information is required and a reanalysis fee will apply.